Resource

Wearables for eCOA: Practical Considerations for Improving Patient Data Capture

This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization, it is clear that newer technologies such as accelerometers and video have the ability to passively or proactively gather more patient data. These wearable devices offer significant advantages in terms...

Resource

How to Maximise Value and Avoid Failure During Life Sciences Dealmaking

Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices, and common pitfalls to avoid in order to maximise value and mitigate risk in life sciences dealmaking, and also answer audience questions. Topics discussed include: - The importance of...

Resource

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & CEO of Aparito, in conversation with Mark Wade, Global Practice Leader at TransPerfect Life Sciences, as they discuss: - The disparity in data capture for pediatric populations. - Considerations...

Resource

Navigating the EU Clinical Trial Regulation Complexities - Current Challenges and Opportunities

As the most significant change in the European Union clinical trial legislative ecosystem in 20 years, the European Union Clinical Trial Regulation 536/2014 (EU CTR) went live on January 31, 2022. The first-year transition period has now ended, and from January 31, 2023, EU Clinical Trial Regulation became compulsory for all new interventional clinical trials of investigational medicinal products. All ongoing trials approved under the previous regulatory framework (EU...

Resource

Part 2: Clinical Trials and COVID-19 Converting to Remote Trial Management – How to Get Started

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect's Trial Interactive hosted Part 2 of the Clinical Trials and COVID-19 webinar series with industry experts to discuss the best strategy to make the...

Resource

Part 4: Clinical Trials and COVID-19: Remote Investigator Meetings

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect's Trial Interactive presents Part 4 of the Clinical Trials and COVID-19 webinar series with industry-expert Penelope K. Manansco to discuss the best...

Resource

Driving Strategic Change: General Counsel in Pharma

TransPerfect Legal Solutions hosted a panel of GCs and legal experts from prominent pharmaceutical companies to discuss their evolving roles and the practical ways legal departments are driving innovation as it relates to people, risk, and data in the pharma industry. PANELISTS: Zafar Qadir – General Counsel, Bicycle Therapeutics Alexandra Pygall – Partner, Head of Life Sciences, Stephenson Harwood Keir LoIacano – Counsel and Vice President of Corporate Development,...

Resource

Shaping The Future of eCOA/ePRO

We have witnessed a rapid and dramatic migration from paper to electronic COA/PRO in the past few years. TransPerfect Life Sciences' C3 Summit brings to you virtual sessions on how the paper to digital migration is evolving, the use and application of eCOA migration technology, and setting up successful eCOA solutions....

Resource

Content Automation to Meet MDR & IVDR Requirements

Marc Miller, President of TransPerfect's Medical Device Solutions chatted with experts from Takeda Pharmaceuticals & QServe to learn about MDR & IVDR labeling compliance while cutting risk, cost, & turnaround by using structured content, process automation, & advanced AI technology....

Resource

Driving Digital Excellence: Delivering Seamless and Personalized Customer-Centric Experiences

The digital evolution in reaching and engaging with global communities, including sponsors, CROs, patients, and HCPs, has drastically shifted the way medical affairs teams connect with key stakeholders. As the industry pursues ways to improve a consumer and patient-centric approach, an omnichannel medical strategy is critical for continuing to drive collaboration, improve customer relations and patient trust, and disseminate and distribute medical information to global...

Resource

Part 1: Clinical Trials and COVID-19: Situation now, its challenges, and the future

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect Life Sciences hosted Part 1 of the Clinical Trials and COVID-19 webinar series with industry experts to exchange ideas and provide insights into the impact of...

Resource

Part 3: Clinical Trials and COVID-19 Adapting to Rapid Change

The novel COVID-19 virus has forced a lot of rapid change in a very short period of time. Personally and professionally, we are all learning how to adapt. While restrictions on our day-today lives impact where, why, and how we interact, we still can come together as a community to learn, grown, and overcome. TransPerfect's Trial Interactive hosted Part 3 of the Clinical Trials and COVID-19 webinar series with representatives from a Sponsor and Site to discuss how they...

Resource

Artificial Intelligence in Life Sciences: Latest Developments Presented by Industry Leaders

Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. Our discussion will cover the following areas: - AI in drug discovery - Predicting adverse events using Natural Language Processing - Rich patient data and wearable devices - The computer...

Resource

Content Solutions for MDR & IVDR Readiness

The implementation dates for MDR (May, 2021) and IVDR (May, 2022) are fast approaching and non-compliant manufacturers are putting their EU market access at risk. These new regulatory requirements have created a “tsunami” of increased content requirements—especially in critical areas such as labeling, post-market surveillance and vigilance, software UI, marketing, and training. Manual processes and document-based systems (like Word, InDesign, and FrameMaker) simply cannot...

Resource

Successful English Build & Language Migration

Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the digital era, shifting to electronic Clinical Outcome Assessments (eCOAs) is becoming more critical than ever. However, it is imperative that the migration of COAs to an electronic format is error...

Resource

Lessons Learned in the Rush for a Vaccine and the Effects on Language Translation: Creating and Adapting Technologies

The rush to a vaccine has accelerated an already dynamic research process. This has led to many innovations and an evolution of procedures. The language translation industry has seen enormous stressors and has had to create and modify processes and technologies similarly. The pandemic has changed society profoundly. The disruption in human and business interactions have not only affected the travel, conference, and hospitality industries but has also changed the clinical...

Resource

The Paper Chase - Clinical Outcome Assessments in the Digital Age

Patients are, at last, gaining a voice in healthcare. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications that should influence policy and treatment decisions. The U.S. Food & Drug Administration (FDA), for example, has launched an initiative, “The Voice of the Patient,” to gather patient perspectives across specific disease areas. Information reported by clinical trial participants...